Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9464863rdf:typepubmed:Citationlld:pubmed
pubmed-article:9464863lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C0333959lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:9464863lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:9464863pubmed:issue6lld:pubmed
pubmed-article:9464863pubmed:dateCreated1998-3-11lld:pubmed
pubmed-article:9464863pubmed:abstractTextThe aim of the current study was to determine if the effects of muscarinic stimulation on left ventricular function and metabolism are greater during beta-adrenergic activation, whether a cyclic GMP-mediated mechanism is responsible, and if this is altered by left ventricular hypertrophy (LVH) induced by aortic valve stenosis. Acetylcholine (Ach) (5 micrograms/kg/min) and/or isoproterenol (Iso) (0.1 micrograms/kg/min) was infused into a branch of the left anterior descending (LAD) artery in 8 control and 8 LVH open-chest anesthetized dogs. LVH increased heart weight, heart-to-body weight ratio and systolic left ventricular pressure. LVH reduced muscarinic receptor density (fmol/mg protein) (control: 149.2+/-18.6; LVH: 77.8+/-8.6), but not affinity. Alone, Ach had no effect on regional force, work or metabolism. Iso increased peak force (g) (control: baseline-7.4+/-0.4; Iso-12.4+/-2.2; LVH: baseline-6.7+/-0.8; Iso-16.3+/-2.7, regional work (g mm/min)) (control: baseline-1250+/-186; Iso-1813+/-409; LVH: baseline-927+/-235; Iso-1244+/-222), and O2 consumption (ml O2/min/100 g) (control: baseline-3.3+/-0.2; Iso-8.1+/-2.0; LVH: baseline-4.8+/-1.0; Iso-8.3+/-1.1). During Iso, Ach reduced segment shortening (control: Iso-14.5+/-1.2; Iso+Ach-10.5+/-1.8; LVH: Iso-10.4+/-1.5; Iso+Ach-7.6+/-1.3) and peak force (control: Iso+Ach-7.7+/-1.0; LVH: Iso+Ach-10.5+/-1.4). Ach also reduced work (control: Iso+Ach-875+/-217; LVH: Iso+Ach-776+/-180) and O2 consumption (control: Iso+Ach-3.4+/-0.7; LVH: Iso+Ach-3.6+/-0.6) in the presence of Iso. Cyclic GMP was higher in the LVH animals during all treatments and was elevated from baseline by Ach in both groups. Neither Iso nor Iso+Ach had a significant effect on cyclic GMP. Thus, the negative functional and metabolic effects of muscarinic stimulation are enhanced during beta-adrenergic activation. This does not, however, appear to be dependent on a cyclic GMP-mediated mechanism. Despite reduced number of muscarinic receptors, this response was not altered by pressure-induced cardiac hypertrophy.lld:pubmed
pubmed-article:9464863pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9464863pubmed:languageenglld:pubmed
pubmed-article:9464863pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9464863pubmed:citationSubsetIMlld:pubmed
pubmed-article:9464863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9464863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9464863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9464863pubmed:statusMEDLINElld:pubmed
pubmed-article:9464863pubmed:monthDeclld:pubmed
pubmed-article:9464863pubmed:issn0300-8428lld:pubmed
pubmed-article:9464863pubmed:authorpubmed-author:WeissH RHRlld:pubmed
pubmed-article:9464863pubmed:authorpubmed-author:TseJJlld:pubmed
pubmed-article:9464863pubmed:authorpubmed-author:ScholzP MPMlld:pubmed
pubmed-article:9464863pubmed:authorpubmed-author:Rabindranauth...lld:pubmed
pubmed-article:9464863pubmed:authorpubmed-author:NaimK LKLlld:pubmed
pubmed-article:9464863pubmed:issnTypePrintlld:pubmed
pubmed-article:9464863pubmed:volume92lld:pubmed
pubmed-article:9464863pubmed:ownerNLMlld:pubmed
pubmed-article:9464863pubmed:authorsCompleteYlld:pubmed
pubmed-article:9464863pubmed:pagination391-401lld:pubmed
pubmed-article:9464863pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9464863pubmed:meshHeadingpubmed-meshheading:9464863-...lld:pubmed
pubmed-article:9464863pubmed:meshHeadingpubmed-meshheading:9464863-...lld:pubmed
pubmed-article:9464863pubmed:meshHeadingpubmed-meshheading:9464863-...lld:pubmed
pubmed-article:9464863pubmed:meshHeadingpubmed-meshheading:9464863-...lld:pubmed
pubmed-article:9464863pubmed:meshHeadingpubmed-meshheading:9464863-...lld:pubmed
pubmed-article:9464863pubmed:meshHeadingpubmed-meshheading:9464863-...lld:pubmed
pubmed-article:9464863pubmed:meshHeadingpubmed-meshheading:9464863-...lld:pubmed
pubmed-article:9464863pubmed:year1997lld:pubmed
pubmed-article:9464863pubmed:articleTitleThe negative functional and metabolic effects of muscarinic stimulation are enhanced by beta-adrenergic activation in control and hypertrophic dog hearts in vivo.lld:pubmed
pubmed-article:9464863pubmed:affiliationUMDNJ-Robert Wood Johnson Medical School, Department of Surgery, New Brunswick, New Jersey 08903-0019, USA.lld:pubmed
pubmed-article:9464863pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9464863pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9464863pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed